
Loading, please wait...

Loading, please wait...

Experts analyzed data from 29,554 participants to investigate the association between the Inflammatory Burden Index (IBI) and pre-diabetes (pre-DM) and diabetes (DM). A higher IBI was significantly correlated with increased prevalence of both conditions, with pre-DM and DM rates reaching 26% and 18% in the highest IBI quartile. These findings suggest that IBI may serve as a useful marker for identifying individuals at risk of developing diabetes.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Experts analyzed data from 29,554 participants to investigate the association between the Inflammatory Burden Index (IBI) and pre-diabetes (pre-DM) and diabetes (DM). A higher IBI was significantly correlated with increased prevalence of both conditions, with pre-DM and DM rates reaching 26% and 18% in the highest IBI quartile. These findings suggest that IBI may serve as a useful marker for identifying individuals at risk of developing diabetes.
2 months ago

Co-administering antiseizure medications and DOACs frequently causes pharmacokinetic interactions, subtherapeutic drug levels, and thromboembolic failures. This review highlights enzyme induction risks, unpredictable outcomes with levetiracetam, and the vital role of therapeutic drug monitoring.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today